Table 3.
Comparison of the two groups' intraoperative complications, in-hospital adverse events and long-term follow-up results
| Variable | RA/DCB (n = 57) | RA/DES (n = 261) | t/χ2/Z | p-value |
|---|---|---|---|---|
| Procedural complications, n (%) | 5 (8.77) | 22 (8.43) | 0.007 | 0.933 |
| Slow or no-reflow, n (%) | 2 (3.51) | 16 (6.13) | 0.211 | 0.646 |
| Perforation, n (%) | 0 (0.00) | 2 (0.77) | 0.000 | 1.000 |
| Burr entrapment, n (%) | 1 (1.75) | 1 (0.38) | 0.068 | 0.794 |
| Guidewire break, n (%) | 1 (1.75) | 2 (0.77) | 0.000 | 1.000 |
| Hypotension, n (%) | 1 (1.75) | 1 (0.38) | 0.068 | 0.794 |
| In-hospital events, n (%) | 0 (0.00) | 7 (2.68) | 0.566 | 0.452 |
| All-cause mortality, n (%) | 0 (0.00) | 4 (1.53) | 0.081 | 0.776 |
| Myocardial infarction, n (%) | 0 (0.00) | 2 (0.77) | 0.000 | 1.000 |
| Stroke, n (%) | 0 (0.00) | 1 (0.38) | 0.000 | 1.000 |
| Long-term MACCE, n (%) | 7 (12.28) | 49 (18.77) | 1.359 | 0.244 |
| All-cause mortality, n (%) | 1 (1.75) | 4 (1.53) | 0.000 | 1.000 |
| Myocardial infarction, n (%) | 0 (0.00) | 3 (1.15) | 0.003 | 0.954 |
| TLR, n (%) | 4 (7.02) | 36 (13.79) | 1.386 | 0.239 |
| Stroke, n (%) | 2 (3.51) | 6 (2.29) | 0.004 | 0.951 |
| Duration of DAPT, m | 10.25 ± 3.53 | 12.28 ± 2.41 | 5.241 | < 0.001 |
| Follow-up CAG rate, n (%) | 29 (50.88) | 122 (46.74) | 0.321 | 0.571 |
| Follow-up duration, m | 15.0 (12.0, 22.5) | 22.0 (15.0, 30.0) | 4.014 | < 0.001 |
MACCE, major adverse cardiovascular and cerebrovascular events; TLR, target lesion revascularization; DAPT, duration of dual antiplatelet therapy; CAG, coronary angiography